Tool

Supplement comparison tool

Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.

Add to comparison (2/4)

	Acarbose	Minoxidil
Category	Leki	Leki
Evidence strength	Strong evidence	Strong evidence
Evidence Score	4/5	5/5
User rating	4.3 (58)	4.5 (168)
Typical dose	Usually started at 25 mg once daily, titrated gradually up to 50–100 mg three times daily with the first bite of each main meal — gradual titration significantly reduces the severity of gastrointestinal side effects	Topical form: 1 ml of 5% solution or the equivalent foam dose, applied twice daily to dry scalp (women sometimes use 5% foam once daily or a 2% solution). Oral form (LDOM, off-label): typically 0.625-5 mg/day, most often 1.25-2.5 mg, individually dosed by a physician
Form	Oral tablets taken right before or with the first bite of a meal	Topical solution or foam; tablets split for the oral form (compounding pharmacy preparation)
Average price	—	35-90 zł za opakowanie formy miejscowej starczające na miesiąc stosowania (cena zależy od koncentracji, formy i producenta — generyki są tańsze niż marki oryginalne)
Monthly cost	—	ok. 35-90 zł/miesiąc dla formy miejscowej; forma doustna (receptura) zwykle wychodzi wyraźnie taniej, ale wymaga recepty i wizyty lekarskiej
Time to effects	The effect on post-meal glycemia is visible from essentially the first correctly timed dose (within hours), while improvement in longer-term markers like HbA1c usually takes 8–12 weeks of regular use at the target dose.	The temporary shedding phase can appear as early as weeks 2-8 of treatment. The first visible signs of regrowth usually appear after 3-4 months of consistent use, with a fully assessable clinical effect after 6-12 months of uninterrupted treatment. The effect requires indefinite continuation; it fades within a few months of stopping.
Who it's for	People with type 2 diabetes whose main problem is post-meal glycemia, assessed by a doctor	Men with early- to moderate-stage androgenetic alopecia, especially in the crown area (less effective where follicles are already completely lost in advanced frontal balding)